Ledger.Open graph →
SEC Form D · Amendment · filed October 30, 2015

Leafline Labs, LLC

Offering
$15.1M
Sold
$14.9M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Cottage Grove, MN
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Mitchell Baruchowitz · Cottage Grove, MNDirector · PromoterEthan Ruby · Cottage Grove, MNDirector · PromoterGary Starr · Cottage Grove, MNPromoterKelly Henry · Cottage Grove, MNPromoterPeter Bachman · Cottage Grove, MNExec · Director · PromoterAndrew Bachman · Cottage Grove, MNDirector · PromoterMark Bachman · Cottage Grove, MNPromoterGlenn Taylor · Cottage Grove, MNDirector · PromoterPaul Bachman · Cottage Grove, MNDirector · PromoterMichael Gargano · Jupiter, FLDirector · PromoterGeoff Smith · Jupiter, FLDirector · PromoterJessica R. Smith · Scottsdale, AZDirector · PromoterViren Mehta · Jupiter, FLPromoterJeffrey R. Rassas · Scottsdale, AZExec · Director · PromoterDouglas Reed · Jupiter, FLPromoterEmmanuel Munson-Regala · Cottage Grove, MNExecJohn R. Wise · Scottsdale, AZDirector · PromoterJonathan R. Read · Scottsdale, AZDirector · PromoterMark Demaria · BLOOMFIELD HILLS, MIDirector · PromoterJoseph B. Baldassarra · Coral Springs, FLPromoterSteven B. Baldassarra · Coral Springs, FLExec · Director · PromoterJose Minski · Fort Lauderdale, FLDirector · PromoterAlejandro Weinstein · Fort Lauderdale, FLDirector · PromoterErnesto Carrizosa · Fort Lauderdale, FLDirector · PromoterBrett D. Huckelbridge · PHOENIX, AZPromoterEmmanuel Munson-Regala · Cottage Grove, MNExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗